Trials / Completed
CompletedNCT00228540
Study to Assess Satisfaction With Modafinil Treatment in Children and Adolescents With ADHD
An 8 Week, Open-Label Study to Characterize the Response to Modafinil (85 mg Film Coated Tablet) Treatment at Dosages Up to 425 mg/Day in Children and Adolescents With Attention Deficit/Hyperactivity Disorder (ADHD) (With an Open Ended Extension Period)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Cephalon · Industry
- Sex
- All
- Age
- 6 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
An 8-week, Open-Label Study to Characterize the Response to Modafinil (85mg Film-Coated Tablet) Treatment at Dosages up to 425mg/Day in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD) (With an Open-Ended Extension Period)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Modafinil |
Timeline
- Start date
- 2005-09-01
- Completion
- 2006-09-01
- First posted
- 2005-09-29
- Last updated
- 2014-05-09
Locations
39 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00228540. Inclusion in this directory is not an endorsement.